Related references
Note: Only part of the references are listed.Formulating elafibranor and obeticholic acid with phospholipids decreases drug-induced association of SPARC to extracellular vesicles from LX-2 human hepatic stellate cells
Cristina Zivko et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2023)
Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model
Samaneh Siapoush et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases
Adriana Psaraki et al.
HEPATOLOGY (2022)
Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Devaraj Ezhilarasan
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2022)
Clinical importance of laboratory biomarkers in liver fibrosis
Goda Aleknaviciute-Valiene et al.
BIOCHEMIA MEDICA (2022)
The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
Danyan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Challenges in the development and establishment of exosome-based drug delivery systems
Jin Wang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
In vitro evaluation of ferutinin on proliferation and osteogenesis differentiation in human unrestricted Somatic stem cells
Zahra Mahmoudi et al.
STEROIDS (2021)
Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?
Alexandra Zisser et al.
BIOMEDICINES (2021)
Animal and Organoid Models of Liver Fibrosis
Yu-long Bao et al.
FRONTIERS IN PHYSIOLOGY (2021)
Farnesoid X receptor (FXR): Structures and ligands
Longying Jiang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Collagen biology and non-invasive biomarkers of liver fibrosis
Morten A. Karsdal et al.
LIVER INTERNATIONAL (2020)
Obeticholic acid for the treatment of NASH
Jordan Hindson
Nature Reviews Gastroenterology & Hepatology (2020)
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Olga Khomich et al.
CELLS (2020)
Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model
Beatrice Anfuso et al.
SCIENTIFIC REPORTS (2020)
Obeticholic acid-a new therapy in PBC and NASH
Roger W. Chapman et al.
BRITISH MEDICAL BULLETIN (2020)
Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
Gamal Shiha et al.
STEM CELLS INTERNATIONAL (2020)
Obeticholic acid for the treatment of nonalcoholic steatohepatitis
Raj A. Shah et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen et al.
CELLS (2020)
Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Ryota Masuzaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Bile Acids and FXR: Novel Targets for Liver Diseases
Mary Stofan et al.
FRONTIERS IN MEDICINE (2020)
Exosome: a significant nano-scale drug delivery carrier
Huan Peng et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway
Xiaoli Rong et al.
STEM CELL RESEARCH & THERAPY (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3
Yuan-Yuan Fan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Obeticholic acid: towards first approval for NASH
Mohammed Eslam et al.
LANCET (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
Jiyu Zhou et al.
ACTA PHARMACEUTICA SINICA B (2019)
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as conducting cells for improvement of liver fibrosis and regeneration
Atsunori Tsuchiya et al.
INFLAMMATION AND REGENERATION (2019)
Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis
Davide Povero et al.
JCI INSIGHT (2019)
HPLC/UV/MS method application for the separation of obeticholic acid and its related compounds in development process and quality control
Michal Dousa et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Liver fibrosis
M. Merve Aydin et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2018)
Recent advancements in the use of exosomes as drug delivery systems
Edwin J. Bunggulawa et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
Hong Wang et al.
EBIOMEDICINE (2018)
Concise Review: MSC-Derived Exosomes for Cell-Free Therapy
Donald G. Phinney et al.
STEM CELLS (2017)
Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation
Da-Gang Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Obeticholic Acid: First Global Approval
A. Markham et al.
DRUGS (2016)
Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis
Manal L. Louka et al.
GENE (2016)
Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway
Zhi-Gang Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
Len Verbeke et al.
SCIENTIFIC REPORTS (2016)
Stem Cell-Derived Exosomes: A Potential Alternative Therapeutic Agent in Orthopaedics
John Burke et al.
STEM CELLS INTERNATIONAL (2016)
Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy
Irina Arutyunyan et al.
STEM CELLS INTERNATIONAL (2016)
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Raphael P. H. Meier et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2015)
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Oscar P. B. Wiklander et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility
Tokiko Nagamura-Inoue
World Journal of Stem Cells (2014)
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
Tingfen Li et al.
STEM CELLS AND DEVELOPMENT (2013)
Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells
Maria Cristina Corotchi et al.
STEM CELL RESEARCH & THERAPY (2013)
Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
Alexander V. Vlassov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Clinical evidence for the regression of liver fibrosis
Elizabeth L. Ellis et al.
JOURNAL OF HEPATOLOGY (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells
Jiang Li et al.
MOLECULAR PHARMACOLOGY (2011)
Exosome function: From tumor immunology to pathogen biology
Jeffrey S. Schorey et al.
TRAFFIC (2008)
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Ajay K. Muddu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Cross-talk between farnesoid-X-receptor (FXR)and peroxisome proliferator-activated receptor γ contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Share Paper
